Ocular allergy/inflammation:
Indications for: PROLENSA
Post-operative inflammation and reduction of ocular pain following cataract surgery.
Adult Dosage:
≥18yrs: 1 drop into the affected eye once daily beginning 1 day prior to surgery, continued on the day of surgery, and through the first 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 mins apart.
Children Dosage:
<18yrs: not established.
PROLENSA Warnings/Precautions:
Sulfite sensitivity. Asthma. May slow or delay wound healing. Bleeding tendencies. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove prior to therapy). Pregnancy (avoid during late pregnancy). Nursing mothers.
PROLENSA Classification:
NSAID.
PROLENSA Interactions:
Concomitant topical corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.
Adverse Reactions:
Anterior chamber inflammation, foreign body sensation, eye pain, photophobia, blurred vision; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).
Generic Drug Availability:
NO
How Supplied:
Soln—1.6mL, 3mL
